NasdaqCM - Delayed Quote USD

Sensei Biotherapeutics, Inc. (SNSE)

0.3152
+0.0127
+(4.20%)
At close: June 2 at 4:00:00 PM EDT
0.3272
+0.01
+(3.81%)
After hours: June 2 at 7:35:24 PM EDT
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
30,207
31,663
37,064
50,188
37,482
Operating Income
-30,207
-31,663
-37,064
-50,188
-37,482
Net Non Operating Interest Income Expense
2,112
2,460
3,480
1,564
130
Other Income Expense
-934
-954
-517
36
558
Pretax Income
-29,029
-30,157
-34,101
-48,588
-36,794
Net Income Common Stockholders
-29,029
-30,157
-34,101
-48,588
-36,794
Diluted NI Available to Com Stockholders
-29,029
-30,157
-34,101
-48,588
-36,794
Basic EPS
-1.15
-1.20
-1.22
-1.58
-1.33
Diluted EPS
-1.15
-1.20
-1.22
-1.58
-1.33
Basic Average Shares
25,153.0510
25,117.2380
27,952.8570
30,703.2950
27,710.6860
Diluted Average Shares
25,153.0510
25,117.2380
27,952.8570
30,703.2950
27,710.6860
Total Operating Income as Reported
-31,158
-32,614
-37,064
-50,188
-37,482
Total Expenses
30,207
31,663
37,064
50,188
37,482
Net Income from Continuing & Discontinued Operation
-29,029
-30,157
-34,101
-48,588
-36,794
Normalized Income
-28,098
-29,206
-33,799
-48,588
-37,361
Interest Income
2,187
2,550
3,624
1,783
800
Interest Expense
75
90
144
219
670
Net Interest Income
2,112
2,460
3,480
1,564
130
EBIT
-28,954
-30,067
-33,957
-48,369
-36,124
EBITDA
-27,929
-28,745
-32,606
-47,022
-35,439
Reconciled Depreciation
1,025
1,322
1,351
1,347
685
Net Income from Continuing Operation Net Minority Interest
-29,029
-30,157
-34,101
-48,588
-36,794
Total Unusual Items Excluding Goodwill
-931
-951
-302
0
567
Total Unusual Items
-931
-951
-302
0
567
Normalized EBITDA
-26,998
-27,794
-32,304
-47,022
-36,006
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 2/4/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers